Anticoagulant Usage and Risk of Thromboembolic Events After Ischemic Stroke in Adults With Cancer.

ABSTRACT:

Background and objectives

Ischemic stroke and cancer often coexist. The aim of this study was to determine the prevalence of cancer among patients with stroke, their antithrombotic treatment patterns, and the risk of subsequent thromboembolic events in a large population-based cohort.

Methods

This retrospective cohort study used data from Optum's deidentified Clinformatics Data Mart Database to assess the 6-month risk of recurrent thromboembolic and major bleeding events identified using validated International Classification of Diseases code algorithms, among adults with active cancer hospitalized with ischemic stroke between October 2020 and September 2021. In addition, we explored the risk of recurrent thromboembolic events stratified by anticoagulant exposure. Landmark a

SUBMITTER: Balali P 

PROVIDER: S-EPMC12614292 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature